Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa

被引:55
作者
Itoh, H
Kataoka, H
Tomita, M
Hamasuna, R
Nawa, Y
Kitamura, N
Koono, M
机构
[1] Miyazaki Med Coll, Dept Pathol 2, Kiyotake, Miyazaki 8891692, Japan
[2] Miyazaki Med Coll, Dept Surg 2, Kiyotake, Miyazaki 8891692, Japan
[3] Miyazaki Med Coll, Dept Parasitol, Kiyotake, Miyazaki 8891692, Japan
[4] Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2000年 / 278卷 / 04期
关键词
hepatocyte growth factor; Kunitz-type proteinase inhibitor; mucosal injury; experimental colitis; immunohistochemistry;
D O I
10.1152/ajpgi.2000.278.4.G635
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocyte growth factor (HGF) activator inhibitor type 1 (HAI-1) and type 2 (HAI-2) are new Kunitz-type serine protease inhibitors that were recently purified and cloned from the human stomach cancer cell line MKN45 as specific inhibitors against HGF activator. Both proteins contain two Kunitz inhibitor domains and are expressed abundantly throughout the gastrointestinal tract, in addition to the placenta, pancreas, and kidney. In this study, to assess the possible roles of HAI-1 and HAI-2 in the intestinal mucosa, we examined the expression of HAI-1 and HAI-2 during regeneration of the intestinal mucosa. Innmuno-histochemical studies revealed that HAI-1 but not HAI-2 was detected more strongly in regenerative epithelium than in normal epithelium, although both proteins were detected throughout the human gastrointestinal tract. During the course of acetic acid-induced experimental colitis in an in vivo mouse model, HAI-1 but not HAI-2 was upregulated in the recovery phase, suggesting that HAI-1 but not HAI-2 is associated with the regeneration of damaged colonic mucosa. Upregulation of HAI-1 may serve to downregulate the proliferative response after initial activation of MET receptor by HGF/scatter factor after an injury.
引用
收藏
页码:G635 / G643
页数:9
相关论文
共 42 条
[1]   Cytokines in inflammatory bowel disease [J].
Beck, PL ;
Wallace, JL .
MEDIATORS OF INFLAMMATION, 1997, 6 (02) :95-103
[2]   HEPATOCYTE GROWTH-FACTOR - A MULTIFUNCTIONAL CYTOKINE [J].
BOROS, P ;
MILLER, CM .
LANCET, 1995, 345 (8945) :293-295
[3]   Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family [J].
Brown, SD ;
Twells, RCJ ;
Hey, PJ ;
Cox, RD ;
Levy, ER ;
Soderman, AR ;
Metzker, ML ;
Caskey, CT ;
Todd, JA ;
Hess, JF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) :879-888
[4]  
Chang JY, 1998, THROMB HAEMOSTASIS, V79, P306
[5]   Characterization of placental bikunin, a novel human serine protease inhibitor [J].
Delaria, KA ;
Muller, DK ;
Marlor, CW ;
Brown, JE ;
Das, RC ;
Roczniak, SO ;
Tamburini, PP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) :12209-12214
[6]   HEPATOCYTE GROWTH-FACTOR SCATTER FACTOR MODULATES INTESTINAL EPITHELIAL-CELL PROLIFERATION AND MIGRATION [J].
DIGNASS, AU ;
LYNCHDEVANEY, K ;
PODOLSKY, DK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (02) :701-709
[7]  
GEBHARD W, 1986, PROTEINASE INHIBITOR, P375
[8]   THE MOUSE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE - CDNA SEQUENCE AND EXON-INTRON STRUCTURE [J].
HOFFER, MJV ;
VANECK, MM ;
PETRIJ, F ;
VANDERZEE, A ;
DEWIT, E ;
MEIJER, D ;
GROSVELD, G ;
HAVEKES, LM ;
HOFKER, MH ;
FRANTS, RR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (03) :880-886
[9]   CDNA SEQUENCING OF MOUSE ALPHA-1-MICROGLOBULIN INTER-ALPHA-TRYPSIN INHIBITOR LIGHT-CHAIN AND ITS EXPRESSION IN ACUTE-INFLAMMATION [J].
ITOH, H ;
IDE, H ;
KATAOKA, H ;
TOMITA, M ;
YOSHIHARA, H ;
NAWA, Y .
JOURNAL OF BIOCHEMISTRY, 1994, 116 (04) :767-772
[10]   Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human [J].
Itoh, H ;
Kataoka, H ;
Hamasuna, R ;
Kitamura, N ;
Koono, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (03) :740-748